Approval for emergency use could come within hours, allowing vaccinations of healthcare workers to start within days
- FDA advisory panel recommends approval of Pfizer Covid vaccine
- States targeted in election fraud lawsuit condemn ‘bogus claims’
- Susan Rice tapped for top domestic policy role in Biden administration
- Sign up to receive First Thing – our daily briefing by email
What happens next with the FDA and the Pfizer vaccine? Well, it cleared the hurdle of being approved by the vaccines committee yesterday – with a couple of dissenting voices, as the Washington Post notes:
The committee voted yes, 17 in favor, four against and one absention. Panel members did not have an opportunity to explain their votes, but at least two dissenters objected to inclusion of 16- and 17-year-olds, given what they described as the low risk of severe disease in that age group and how few had participated in the trial.
“I would have voted ‘yes’ most enthusiastically had the language been ‘ … 18 years of age and older,’ ” said David Kim, director of the division of Vaccines in the Office of Infectious Disease and HIV/AIDS Policy in the Department of Health and Human Services.
If as expected, the FDA follows quickly with an emergency authorization, the shots will start being moved to the states within 24 hours, according to officials at Operation Warp Speed. Inoculations could begin early next week.
After the FDA authorization, an advisory committee to the Centers for Disease Control and Prevention will vote on whether to recommend the vaccine and for which groups. First in line to be inoculated are health care personnel and residents and staff of long-term care facilities, according to its previous recommendations. But states will have the final say on who gets the first shots and where they are administered. Those considerations are complicated by extreme logistics challenges, including the sub-Antarctic storage temperatures the vaccine requires.
Hi, and welcome to our live coverage of US politics for Friday. Here’s a catch up on where we are, and some of what we might see today:
Donald Trump | The Guardian
1. Trump from Michael_Novakhov (197 sites)